Skip to main content
. Author manuscript; available in PMC: 2021 Aug 12.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2021 Mar 4;30(5):105692. doi: 10.1016/j.jstrokecerebrovasdis.2021.105692

Table 4.

Effect of Insurance Status on Outcomes for Stroke Patients Receiving Intra-Arterial Treatments.a

Model 1* Model 2b
OR (95% CI) AOR (95% CI) AOR (95% CI)
Symptomatic ICH Private Insurance Ref Ref Ref
Medicare 1.17 (1.003–1.36) 1.13 (0.94–1.35) 1.09 (0.91–1.31)
Medicaid 1.23 (0.96–1.56) 1.18 (0.92–1.51) 1.15 (0.89–1.48)
None 1.12 (0.79–1.60) 1.07 (0.74–1.54) 1.08 (0.75–1.55)
In-hospital death Private Insurance Ref Ref Ref
Medicare 1.61 (1.45–1.78) 1.09 (0.97–1.24) 1.05 (0.93–1.19)
Medicaid 0.96 (0.80–1.15) 1.00 (0.83–1.21) 0.98 (0.81–1.19)
None 1.34 (1.07–1.69) 1.36 (1.07–1.73) 1.36 (1.07–1.73)
Discharge to Home Private Insurance Ref Ref Ref
Medicare 0.44 (0.41–0.47) 0.76 (0.70–0.83) 0.78 (0.71–0.85)
Medicaid 0.87 (0.78–0.98) 0.85 (0.75–0.96) 0.85 (0.75–0.96)
None 1.67 (1.44–1.94) 1.91 (1.62–2.25) 1.90 (1.61–2.24)

Abbreviations: CI=confidence interval; ICH=intracranial hemorrhage; IAT=intra-arterial treatment; IVT=intravenous treatment.

a

Patients received IAT only or IVT+IAT.

*

Adjusted by age, sex, race, NIHSS score, arrival by ambulance.

b

Adjusted by age, sex, race, NIHSS score, arrival by ambulance, prior stroke, hypertension, dyslipidemia, coronary artery disease, heart failure, diabetes mellitus, atrial fibrillation, current smoker.